Tryp Therapeutics Inc. Stock OTC Markets
Equities
TRYPF
CA89854F1062
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0562 USD | +32.24% | +14.69% | +64.81% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 7.29M 5.35M |
---|---|---|---|---|---|
Net income 2024 * | -5M -3.67M | Net income 2025 * | -5M -3.67M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.31% |
1st Jan change | Capi. | |
---|---|---|
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- TYP Stock
- TRYPF Stock